Arthrosi Announces First Patient Dosed in Replicate Pivotal Phase 3 REDUCE 1 Trial of Lead ...
Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...
Pharmabiz1 天
Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of ...
Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...
Woman's World on MSN2 天
Early Gout Symptoms You Shouldn't Ignore-It's Not Just Big Toe Pain
If you've ever been going about your day only to get hit with excruciating joint pain, it could be gout. While this type of ...
腾讯网2 天
《内科学年鉴》重磅发布！2025「痛风临床诊疗建议」来啦
点击“蓝字”关注我们引言：痛风诊疗，十问十答。痛风，是一种由单钠尿酸盐晶体在关节、肌腱、滑囊及其他组织中沉积引起的炎症性关节炎，发病率逐年上升，对患者的健康和生活质量造成了严重威胁。痛风的发病机制复杂，与尿酸代谢紊乱密切相关，当血液中的尿酸水平超过饱 ...